Dialogue with Decision Makers
ISPOR Roundtables and Councils bring together key decision-making stakeholders from around the world to share innovative research methods and health policy developments. The objective of these initiatives is to provide an unbiased forum that convenes key thought leaders who can learn from each other to advance the science of health economics and outcomes research.
ISPOR Health Science Policy Council
The ISPOR Health Science Policy Council (HSPC) is an advisory body to the Society on key scientific research and policy issues in health economics and outcomes research (HEOR). It is composed of ISPOR Past-Presidents and other distinguished experts in HEOR.
ISPOR Health Technology Assessment Council
The ISPOR Health Technology Assessment (HTA) Council is a global body of healthcare decision makers who advises the Society toward the goal of bridging the gap between outcomes research and healthcare decision making.
ISPOR Health Technology Assessment Roundtables
ISPOR HTA Roundtables provide a forum for HTA thought leaders and healthcare stakeholders to discuss, debate, and share health technology issues. ISPOR HTA Roundtables seek to help fulfill the Society’s HTA Council mission of sharing issues and recommendations globally and providing guidance on the translation and use of outcomes studies to help inform HTA and healthcare decision-making processes. Roundtable attendees include representatives from public HTA bodies, public and private payers, decision makers, and government-contracted academic centers (if no HTA body exists in the country).
ISPOR convenes the following HTA Roundtables annually:
- HTA-P&T Roundtable—North America
- HTA Roundtable—Asia Pacific
- HTA Roundtable—Europe
- HTA Roundtable—Latin America
- HTA Roundtable—Middle East and Africa
Health Technology Assessment Council Working Groups
ISPOR HTA Council working groups develop guidance on good practices used to inform evidence-based, population-based (ie, payer) decision making for new interventions, with an emphasis on HTA approaches.
• International Initiatives on the Assessments of the Value of Medical Technologies
• Overview of Good Practices for Synthesizing and Using Evidence in Healthcare Decision Making
Special Interest Group Reports
ISPOR Special Interest Groups develop valuable tools and reports for the global heath economic and outcomes research audience. Special Interest Groups cover a wide range of topics, such as oncology, medical devices and diagnostics, medication adherence, rare diseases, and HTA.
Active HTA-Related Special Interest Groups
The following are active ISPOR Special Interest Groups that relate to HTA issues. ISPOR Special Interest Groups are open exclusively to ISPOR’s membership and all members are welcome to join active groups.
- Value Assessment of Medical Devices Working Group
Objective: To provide a definitional and methodological framework for the challenges facing the value assessment of medical devices and how these challenges can be overcome.
- Stated-Preference Research in the European Union Working Group
Objective: To map which stated preference methods are being used as part of European regulatory decisions—approval, reimbursement, and pricing.
ISPOR provides a number of country/region specific resources and tools for healthcare decision making.
- Global Healthcare Systems Road Maps
- Pharmacoeconomic Guidelines Around the World
- ISPOR Health Technology Assessment (HTA) Chair, Finn Børlum Kristensen, MD, PhD, presented about HTA Development in China and Globally at the 1st China HTA Conference in Beijing, China on 26 October 2018. Dr. Kristensen presented about strengthening HTA methodology in China and globally, as well as about the HTA Training Program and HTA Central.
ISPOR also contributes to key guidance documents that are published by other organizations.
European Commission’s Public Consultation on Strengthening EU Cooperation on Health Technology Assessment (HTA)
EUnetHTA’s Joint Action 2 on Health Technology Assessment (HTA)
- European Commission HTA Network
- WHO Geneva